Quantitative structure-retention-pharmacokinetic relationship studies

Drug Metabolism Letters

Volumn 2, Issue 2, 2008, Pages 130-137

  Agatonovic Kustrin, Snezana ^a   Turner, Joseph V ^b   Glass, Beverley D ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Generalized ANN; Physicochemical parameter; QSPR; Theoretical descriptors

Indexed keywords

ACEBUTOLOL; ALPRAZOLAM; ALPRENOLOL; AMOBARBITAL; ATENOLOL; CHLORPROMAZINE; CLORAZEPATE; DIAZEPAM; DICLOFENAC; FLUNITRAZEPAM; HEXOBARBITAL; HYDROGEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LORAZEPAM; METOPROLOL; MIDAZOLAM; NADOLOL; NAPROXEN; NITRAZEPAM; OXAZEPAM; OXPRENOLOL; PENTOBARBITAL; PHENOBARBITAL; PINDOLOL; PROMETHAZINE; SECBUTABARBITAL;

ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESEARCH; DRUG RETENTION; DRUG SOLUBILITY; HUMAN; HYDROGEN BOND; MICELLAR LIQUID CHROMATOGRAPHY; MOLECULAR MODEL; MOLECULAR SIZE; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SCIENTIFIC LITERATURE; SENSITIVITY ANALYSIS; THREE DIMENSIONAL IMAGING; VALIDATION STUDY;

CHROMATOGRAPHY, LIQUID; DRUG DESIGN; HALF-LIFE; HUMANS; HYDROGEN BONDING; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; NEURAL NETWORKS (COMPUTER); PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLUBILITY; TISSUE DISTRIBUTION;

EID: 47249090510     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231208784040933     Document Type: Article

References (51)

1. Grabowski, H. J. Int. Economic Law, 2002, 5, 849-60.
2. Armstrong, D. W.; Nome, F. Anal. Chem., 1981, 53, 1662-66.
3. Berthod, A.; Girard, I.; Gonnet, C. Anal. Chem., 1986, 58, 1356-58.
4. Molero-Monfort, M.; Madina-Biosca, Y.; Sagrado, S.; Villanueva-Camanas, R. M.; Medina-Hernandez, M. J. J. Chromatogr. A, 2000, 870, 1-11.
5. Wessel, M. D.; Jurs, P. C.; Tolan, J. W.; Muskal, S. M. J. Chem. Inf. Comput. Sci., 1998, 38, 726-35.
6. Artursson, P.; Karlsson, J. Biochiem. Biophys. Res. Commun., 1991, 175, 880-85.
7. Tavelin, S.; Milovic, V.; Ocklind, G.; Olsson, S.; Artursson, P. J. Pharmacol. Exp. Ther., 1999, 290, 1212-21.
8. Zhu, C.; Jiang, L.; Chen, T.; Hwang, K. K. Eur. J. Med Chem., 2002, 37, 399-407.
9. Beigi, F.; Gottschalk, I.; Lagerquist Hagglund, C.; Haneskog, L.; Brekkan, E.; Zhang, Y.; Osterberg, T.; Lundahl, P. Int. J. Pharm., 1998, 164, 129-37.
10. Mager, D. E. Adv. Drug Deliv. Rev., 2006, 58, 1326-56.
11. Pidgeon, C.; Ong, S.; Liu, H.; Qiu, X.; Pidgeon, M.; Dantzig, A. H.; Munroe, J.; Hornback, W. J.; Kasher, J. S.; Glunz, L.; Szczerba, T. J. Med. Chem., 1995, 38, 590-4.
12. Yang, C. Y.; Cai, S. J.; Liu, H.; Pidgeon, C. Adv. Drug Deliv. Rev., 1997, 23, 229-56.
13. Palm, K.; Stenberg, P.; Luthman, K.; Artursson, P. Pharm. Res., 1997, 14, 568-71.
14. Theil, F. P.; Guentert, T. W.; Haddad, S.; Poulin, P. Toxicol. Lett., 2003, 138, 29-49.
15. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors. Wiley-VCH: Weinheim, 2000.
16. Turner, J. V.; Maddalena, D. J.; Agatonovic-Kustrin, S. Pharm. Res., 2004, 21, 68-82.
17. Turner, J.V.; Maddalena, D.J.; Cutler, D.J. Int. J. Pharm., 2004, 270, 209-19.
18. Estrada, E. J. Phys. Chem., 2002, 106, 9085-91.
19. Ritschel, W. A.; Kearns, G. L. Handbook of Basic Pharmacokinetics - Including Clinical Applications. American Pharmacists Association: Washington DC, 2004.
20. Cuenca-Benito, M.; Sagrado, S.; Villanueva-Camanas, R. M.; Medina-Hernandez, M. J. J. Chromatogr. A, 1998, 814, 121-32.
21. Martin-Biosca, Y.; Molero-Monfort, M.; Sagrado, S.; Villanueva-Camañas, R. M.; Medina-Hernández, M. J. Bioamed. Chromatogr., 1999, 13, 478-92.
22. Yen, T. E., Agatonovic-Kustrin, S.; Evans, A. M.; Nation, R. L.; Ryand, J. J. Pharm. Biomed. Anal., 2005, 38, 4172-8.
23. Turner, J. V.; Maddalena, D. J.; Cutler, D. J., Agatonovic-Kustrin, S. J. Pharm. Sci., 2003, 92, 518-25.
24. Reed, R. IEEE Trans. Neural Netw., 1993, 4, 740-47.
25. Basak, S. C.; Balaban, A. T.; Grunwald, G, D.; Gute, B. D. J. Chem. Inf. Comput. Sci., 2000, 40, 891-98.
26. van de Waterbeemd, H.; Camenisch, G.; Folkers G.; Chretien, J. R., Raevsky. O. A. J. Drug, Target, 1998 6, 151-65.
27. Breyer, E. D.; Strasters, J. K.; Khaledi, M. G. Anal. Chem., 1991, 63, 828-33.
28. Escuder-Gilabert, L.; Sagrado, S.; Villanueva-Camanas, P. M.; Medina-Hernandez, M. J. Anal. Chem., 1998, 70, 28-34.
29. Sauchis-Mallols, J.; Villanueva-Camanas, R.; Sagrado, S.; Medina-Hernandez, M. Chromatographia, 1997, 46, 605-12.
30. Molero-Monfort, M.; Sagrado, S,; Villanueva-Camanas, R. M., Medina-Hernandez, A. J. Biomed. Chromatogr., 1999, 13, 394-400.
31. Quinones-Torrelo, C.; Sagrado, S.; Villanueva-camanas, R. M.; Medina-Hernandez, M. J. J. Med. Chem., 1999. 42, 3154-62.
32. Dearden, J. C. Environ. Health Perspect., 1985, 61, 203-28.
33. Egan, W. J,; Merz, K. M. J.; Baldwin, J. J. J. Med. Chem., 2000, 43, 3867-77.
34. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernas, H.; Karlen. A. J. Med. Chem., 1998, 41, 4939-49.
35. Farnum, M. A.; Zukoski, C. F. Biophys. J., 1999, 76, A127-A27.
36. Ooi, T.; Oobatake, M.; Némethy, G.; Scheraga, H. A. Proc. Natl. Acad. Sci. USA, 1987, 84, 3086-90.
37. Mennella, J. A.; Beauchamp, G. K. N. Engl. J. Med., 1991, 325, 981-85.
38. Gorse, D.; Rees, A.; Kaczorek, M.; Lahana, R. Drug Discov. Today, 1999, 4, 257-64.
39. Grassy, G.; Calas, B.; Yasri, A.; Lahana, R,; Woo, J.; Iyer, S.; Kaczorek, M.; Floc'h, R.; Buelow, R. Nat. Biotechnol,, 1998, 16, 748-52.
40. Kier, L. B,; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis. Wiley: New York, 1986.
41. Estrada E. Chem. Phys. Lett., 2001, 336, 248-52.
42. Clarke, E. G. C.; Moffat, A. C. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Post-Mortem Materials. Pharmaceutical Press: London, 1986.
43. Potts, R. O.; Guy. R. H. Pharm. Res., 1993, 10, 6315-37.
44. Hansch, C,: Leo, A.; Hoekman, D. H. Exploring QSAR: Fundamentals and Applications in Chemistry and Biology. American Chemical Society: Washington, 1995.
45. Meng, Z., Carper, W, R. J. Mol. Struct., 2000, 531,
46. Kier, L. B. Molecular Orbital Theory in Drug Research. Academic Press: New York, 1971.
47. Ertl, P.; Rohde, B., Selzci, P. J. Med. Chem., 2000, 43, 3714-17.
48. Klopman, G.; Zhu, H. J. Chem. Inf. Comput. Sci., 2001, 41, 439-45.
49. Gutman, I.; Miljkovi, O.; Caporossi, G.; Hansen, P. Chem. Phys. Lett., 1999, 306, 366-72.
50. Kier, L, B.; Hall, L. H. Molecular Connectivity in Chemistry and Drug Research. Academic Press: Now York, 1976.
51. Randic, M. J. Chem. Inf. Comput. Sci., 2001, 41, 607-13.